Who has invested in LP Pharmaceuticals?

Sequoia Capital China, SDIC Innovation are named among the investors backing LP Pharmaceuticals.

LP Pharmaceuticals Funding: $102M Raised, Series C (2020)

LP Pharmaceuticals funding overview

LP Pharmaceuticals is based in Burlingame, California. LP Pharmaceuticals has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for LP Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Sequoia Capital China, SDIC Innovation. 2 distinct backers are named across the disclosed rounds.

LP Pharmaceuticals at a glance

Total raised: $102M
Latest round: Series C
Latest round date: August 2020
Headquarters: Burlingame, California
Notable investors: Sequoia Capital China, SDIC Innovation

Frequently asked about LP Pharmaceuticals funding

How much has LP Pharmaceuticals raised?: LP Pharmaceuticals has raised $102M in total disclosed funding across the rounds on record.
Who has invested in LP Pharmaceuticals?: Sequoia Capital China, SDIC Innovation are named among the investors backing LP Pharmaceuticals.
What was the latest LP Pharmaceuticals funding round?: The most recent disclosed round is a Series C, announced in August 2020.
Where is LP Pharmaceuticals based?: LP Pharmaceuticals is based in Burlingame, California.
When did LP Pharmaceuticals last raise?: The last disclosed LP Pharmaceuticals round closed in August 2020 at Series C.

LP Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.

LP Pharmaceuticals Funding: $102M Raised, Series C (2020)

LP Pharmaceuticals funding overview

LP Pharmaceuticals at a glance

Frequently asked about LP Pharmaceuticals funding

Companies related to LP Pharmaceuticals (28)

Browse related funding lists (4)